TITLE

Crohn's disease or abdominal tuberculosis?

AUTHOR(S)
Forbes, A.
PUB. DATE
December 2007
SOURCE
Gut;Dec2007, Vol. 56 Issue 12, p1757
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information to the online tutorial entitled "Crohn's disease or abdominal tuberculosis" offered by the magazine. It states that the article focuses on study of patients suffering from Crohn's disease. In addition, it also highlights the utilization of the Crohn's Disease Activity Index or Harvey Bradshaw index for the disease's diagnosis. Furthermore, the use of different drugs in managing post-operative patients are also discussed.
ACCESSION #
28105586

 

Related Articles

  • Irritable Bowel Syndrome—Type Symptoms in Patients With Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation? Keohane, John; O'Mahony, Caitlin; O'Mahony, Liam; O'Mahony, Siobhan; Quigley, Eamonn M.; Shanahan, Fergus // American Journal of Gastroenterology;Aug2010, Vol. 105 Issue 8, p1789 

    OBJECTIVES:Do gastrointestinal symptoms in patients with inflammatory bowel disease (IBD) in apparent remission reflect the coexistence of irritable bowel syndrome (IBS) or subclinical inflammation? The aims of this study were as follows: (i) to prospectively determine the prevalence of IBS...

  • The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn’s disease. Tamaki, Hiroyuki; Nakase, Hiroshi; Matsuura, Minoru; Inoue, Satoko; Mikami, Sakae; Ueno, Satoru; Uza, Norimitsu; Kitamura, Hiroshi; Kasahara, Katsuhiro; Chiba, Tsutomu // Journal of Gastroenterology;2008, Vol. 43 Issue 10, p774 

    Recent evidence indicates that intravenous or oral therapy with tacrolimus (FK-506) is effective in treating patients with Crohn’s disease. We evaluated the usefulness of tacrolimus therapy for Japanese patients with refractory Crohn’s disease. Fourteen adult Japanese patients with...

  • Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients with IBD after Discontinuation of One-Year Infliximab Therapy. Dai, Cong; Liu, Wei-Xin; Jiang, Min; Sun, Ming-Jun // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Aim: To assess the endoscopic activity and Clinical activity after a one-year period of infliximab therapy and to evaluate the association between mucosal healing and need for retreatment after stopping infliximab in patients with Inflammatory bowel disease (IBD). Methods: The data from 109...

  • LEKI ANTYCYTOKINOWE W TERAPII CHOROBY LEÅšNIOWSKIEGO-CROHNA - TERAŹNIEJSZOŚĆ I PRZYSZŁOŚĆ. ANDRZEJCZAK, DARIUSZ // Problemy Terapii Monitorowanej;sep2009, Vol. 20 Issue 3, p209 

    Crohn's disease is one of the chronic inflammatory bowel diseases. In the course of this inflammatory process among other factors pro-inflammatory cytokines have a great significance. The drugs blocking biological effects of cytokines could be a new approach to the treatment of the disease. In...

  • Evaluation and Management of the Patient With Suspected Recurrent Crohn's Disease: The Postoperative Crohn's Disease Patient. Dubinsky, Marla // American Journal of Gastroenterology;Jun2007 Supplement, Vol. 102, pS38 

    The article focuses on the management and assessment of suspected recurrence of Crohn's disease in postoperated patients. Although surgery is found to be an important option for the treatment of such disease, extensive or repeated procedure has remained controversial due to a belief of negative...

  • Impact of preoperative weight loss on postoperative morbidity. Higgens, C. S.; Keighley, M. R. B.; Allan, R. N. // Journal of the Royal Society of Medicine;Aug1981, Vol. 74 Issue 8, p571 

    Clinical observations in developing countries and experimental studies in animals suggest that preoperative weight loss adversely affects postoperative morbidity. Since it is not clear whether these findings can be applied to surgical series in European countries, we have studied 106...

  • Management of Postoperative Crohn's Disease. Ng, Siew C.; Kamm, Michael A. // American Journal of Gastroenterology;Apr2008, Vol. 103 Issue 4, p1029 

    Three-quarters of the patients with Crohn's disease (CD) require surgery involving a resection in the course of their disease. Even if all macroscopically involved bowel is removed, the disease usually recurs proximal to, and at, the anastomosis. This often leads to the recurrent need for...

  • Ileocecal Strictureplasty for Crohn's Disease: Long-Term Results and Comparison with Ileocecal Resection. Tonelli, Francesco; Fazi, Marilena; di Martino, Carmela // World Journal of Surgery;Dec2010, Vol. 34 Issue 12, p2860 

    Background: The aim of the present study was to evaluate strictureplasty as the first choice for surgical treatment for Crohn's terminal ileitis. Methods: Between 1996 and 2000 we performed Finney-shaped ileocecal strictureplasty (ICS), doubling up the diseased terminal ileum, in 14 patients...

  • Postoperative Health-Care Utilization in Crohn's Disease: The Impact of Specialist Care. Nguyen, Geoffrey C; Saibil, Fred; Steinhart, A Hillary; Li, Qi; Tinmouth, Jill M // American Journal of Gastroenterology;Oct2012, Vol. 107 Issue 10, p1522 

    OBJECTIVES:Crohn's disease (CD) patients frequently require surgery. We sought to characterize postoperative health-care utilization and its impact on outcomes.METHODS:We assembled a population-based cohort of CD patients who underwent first surgery in Ontario, Canada, between 1996 and 2009. We...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics